Hormonal levels of leptin, insulin, ghrelin, and neuropeptide Y in lean, overweight, and obese Saudi females

Saudi Medical Journal

Volumn 28, Issue 8, 2007, Pages 1191-1197

  Daghestani, Maha H ^a,b   Ozand, Pinar T ^b   Al Himadi, Ahmed R ^a   Al Odaib, Ali N ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; INSULIN; LEPTIN; NEUROPEPTIDE Y; PEPTIDE HORMONE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIET RESTRICTION; FEMALE; HORMONE RESISTANCE; HOSPITAL DEPARTMENT; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; METABOLISM; OBESITY; SAUDI ARABIA; BLOOD; CASE CONTROL STUDY; PHYSIOLOGY;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN; LEPTIN; NEUROPEPTIDE Y; OBESITY; OVERWEIGHT; PEPTIDE HORMONES; SAUDI ARABIA;

EID: 35848963642     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Bray GA. Epidemiology, risks and pathogenesis of obesity. Meat Sci 2005; 71: 2-7.
2. Al-Mahroons F, Al-Roomi K. Overweight and obesity in the Arabian Peninsula: An overview. J R Soc Health 1999; 119: 251-253.
3. Al-Rukban MO. Obesity among Saudi male adolescents in Riyadh, Saudi Arabria. Saudi Med J 2003; 24: 27-33.
4. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671.
5. Baskin DG, Figlewicz-Lattermann D, Seeley RJ, Woods SC, Porte D Jr, Schwartz MW. Insulin and leptin: Dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 1999; 848: 114-1123.
6. Niswendor KD, Gallis B, Blevins JE, Corson MA, Schwartz MW, Baskin DG. Immunocytochemical Detection of Phosphatidylinositol 3-kinase Activation by Insulin and Leptin. J Histochem Cytochem 2003; 51: 275-283.
7. Niswender KD, Schwartz MW. Insulin and leptin revisited: Adiposity signals with over lapping physiological and intracellular signalling capabilities. Front Neuroendocrinol 2003; 24: 1-10.
8. Marks JL, Porte D Jr, Stahl WL, Baskin DG. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 1990; 127: 3234-3236.
9. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah Lt, Morgan PJ, et al. Coexpression of leptin receptor and preproneuropeptide Y mRNA in accurate nucleus of mouse hypothalamus. J Neuroendocrinol 1996; 8: 733-735.
10. Ikeda H, West DB, Pustek JJ, Figlewicz DP, Greenwood MRC, Porte D Jr, et al. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 1986; 7: 391-386.
11. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997; 94: 8878-8883.
12. Ramos EJ, Meguid MM, Campos AC, Coelho JC. Neuropeptide Y, à Melanocyte-stimulating hormone, and monoaumines in food intake regulation. Nutrition 2005; 21: 269-279.
13. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-532.
14. Smith FJ, Campfield LA, Moschera JA, Bailon PS, Burn P. Feeding inhibition by neuropeptide Y. Nature 1996; 382: 307.
15. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of target of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101-1106.
16. Gerozissis K. Brain insulin and feeding: A bi-directional communication. Eur J Pharmacol 2004; 490: 1-3.
17. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. Insulin in the brain: A hormonal regulator of energy balance. Endocr Rev 1992; 13: 387-414.
18. Zhang Y, Proenca R, Maffei M, Barone M, Leoppold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
19. Golden PL, Maccagnan TJ, Pardridge WM. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 1997; 99: 14-18.
20. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neutral networks. Science 1995; 269: 546-549.
21. Halaas JL, Ravussin E, Gajiwala KS, Maffei M, Cohen SL, Chait BT, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
22. Maffei M, Hallaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in humans and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161.
23. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: The tale of an obesity gene. Diabetes 1996; 45: 1455-1462.
24. Kojima IM, Hosada H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
25. Howard AD, Feighner HD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. A receptor in pituitary and hypothalamus that functions in the growth hormone release. Science 1996; 273: 974-977.
26. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, et al. Preliminary evidence that Gherelin, the natural GH secretagogue (GHS)-receptor legand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000; 23: 493-495.
27. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adipoosity in rodents. Nature 2000; 407: 908-913
28. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role of ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
29. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000; 141: 4797-4800.
30. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in human. J Clin Endocrinol Metab 2001; 86: 5992-5995.
31. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroecdocrine and peripheral activities of ghrelin: Implications in metabolism and obesity. Eur J Pharmacol 2002; 440: 235-254.
32. Holst B, Schwartz TW. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol Sci 2004; 3: 113-117.
33. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, et al. Ghrelin, an endogenous growth hormone secreragogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathways. Diabetes 2001; 50: 227-232.
34. Willesen MG, Kristensen P, Romer J, CO-localization of growth hormone secretagogue receptor and NPY on RNA in the arcuate nucleus of the rat. Neuroendocrinology 1999; 70: 306-316.
35. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, et al. Stomach is a major source of circulating ghrelin, and feeding states that determines plasma ghrelin-like immunoactivity levels in human. J Clin Endocrinol Metab 2001; 86: 4753-4758.
36. Cummings DE, Purnell JQ, Frayo RS, Schmodova K, Wisse BE, Weigle DA. A preprandial rise in plasmaghrelin levels suggest a role in meal initiation in human. Diabetes 2001; 50: 1714-1799.
37. Tschop M, Weyer C, Tataranni PA, Devanaraya V, Ravussin E, Heiman M. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709.
38. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244.
39. Park HS, Lee K, Kim YS, Park CY. Relationship between fasting plasma ghrelin levels and metabolic parameters in children and adolescents. Metab Clin Exp 2005; 54: 925-929.
40. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyoe MR, et al. Strum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
41. Mendez-Sanchez N, Gonzales V, King-Martinez AC, Sanchez H, Uribe M. Plasma leptin and cholesterol saturation of bile are. correlated in obese women after weight loss. J Nutr 2002; 132: 2195-2198.
42. Huang KC, Lin RC, Kormas N, Lee LT, Chen CY, Gill TP, et al. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids,and pubertal development in nondiabetic adolescents. Int J Obes Relat Metab Disord 2004; 28: 470-475.
43. Haffner SM, Gingerich RL, Miettinen H, Stern MP. Leptin concentration in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord 1996; 20: 904-908.
44. Ruhl C, Everhart J. Leptin concentrations in the United States: Relation with demographic and anthropometric measures. Am J Clin Nutr 2001: 74: 295-301.
45. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, et al. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: Cross sectional study. BMJ 1996; 313: 965-969.
46. Hanley AJ, Harris SB, Gan XJ, Kwan J, Zinman B, Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 1997; 20: 1408-1415.
47. De Silva A, De Courten M, Zimmet P, Nicholson G, Kotowicz MP, pasco J, et al. Lifestyle factors fail to explain the variation in plasma leptin concentrations in women. Nutrition 1998; 14: 653-657.
48. Bennett FI, McFaralane-Anderson N, Wills R, Luke A, Cooper RS, Forrester TE. Leptin concentration in women is influenced by regional distribution of adipose tissue. Am J Clin Nutr 1997; 66: 1340-1344.
49. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997; 278; 1803-1805.
50. Sahu A. Leptin signalling in the hypothalamus: Emphasis on energy homeostasis and leptin resistance. Neuroendocrinology 2003; 24: 225-253.
51. Niswender A, Baskin DG, Schwartz MW. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostatis. Trends Endocrinol Metab 2004; 15: 362-369.
52. Hansen TK, Dall R, Hosada H, Kojima M, Kangawa K, Christiansen JS, et al. Weight loss increases circulating levels of ghrelin in human obesity. Endocrinology 2002; 56: 203-206.
53. Soriano-Guillen L, Barrios V, Vampos-Barros A, Argante J. Ghrelin levels in obesity and anorexia: Effect of weight reduction or recuperation. J Pediatr 2004; 144: 36-42.
54. Haluzik M, Matoulek M, Scavina S. The change of serum leptin levels after 24-hours starvation in morbidly obese and lean subjects. Obes Res 1999; 77: 78.
55. Tomaszuk A, Simpson C, Williams G. Neuropeptide Y, the hypothalamus and regulation of energy homeostasis. Horm Res 1996; 46: 53-58.
56. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Oikawa S. Effects of insulin, leptin, and glucagon on ghrelin secretion from isolated perfused rat stomach. Regal Pept 2004; 119: 77-81.
57. Barrazoni R, Zanetti M, Stebel M, Biolo G, Cattin L, Guarnieri G. Hyperleptinemia prevents increased plasma ghrelin concentration during short-terms moderate caloric restriction in rats. Gastroenterology 2003; 124: 1188-1192
58. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988.
59. Weirup N, Svensson H, Mudler H, Sundler F. The ghrelin cell: A novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-69.
60. Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Woltz M, Lugger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: A double-blind, placebo-controlled crossover clamp study. Diabetes 2003; 52: 16-20.
61. Caixas A, Bashore C, Nasw W, Pi-Sunyer F, Lafere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 2002; 87: 1902-1906.
62. Saad MF, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002; 87: 3997-4000.
63. Reimer MK, Pacini G, Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003; 144: 916-921.
64. Malik IA, English PJ, Ghatei MA, Bloom SR, MacFarlane IA, Wilding JP. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol 2004; 60: 137-141.
65. Nam SY, Kratzse J, Kim KR, Kim KW, Lim SK, Marcus C. Cerobrospinal fluid and plasma concentrations of leptin, NYP, and alpha-MESH in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab 2001; 86: 4849-4853.
66. Zahorska-Markiewicz B, Obuchowicz E, Waluga M, Tkace E, Herman ZS. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs. Med Sci Monit 2001; 7: 403-408.